Cargando…
Tear proteomics in dry eye disease
Dry eye disease (DED) is a multi-factorial ocular surface condition driven by compromised ocular lubrication and inflammation which leads to itching, dryness, and vision impairment. The available treatment modalities primarily target the acquired symptoms of DED including tear film supplements, anti...
Autores principales: | Kannan, Ramaraj, Das, Samayitree, Shetty, Rohit, Zhou, Lei, Ghosh, Arkasubhra, Deshpande, Vrushali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276753/ https://www.ncbi.nlm.nih.gov/pubmed/37026251 http://dx.doi.org/10.4103/IJO.IJO_2851_22 |
Ejemplares similares
-
Tear biomarkers in dry eye disease: Progress in the last decade
por: Kumar, Nimisha R, et al.
Publicado: (2023) -
Ion channels in dry eye disease
por: Ashok, Nikhil, et al.
Publicado: (2023) -
Autophagy in dry eye disease: Therapeutic implications of autophagy modulators on the ocular surface
por: Jeyabalan, Nallathambi, et al.
Publicado: (2023) -
Ocular Surface Infection Mediated Molecular Stress Responses: A Review
por: Das, Samayitree, et al.
Publicado: (2022) -
Resveratrol for dry eye disease – Hope or Hype?
por: Shetty, Rohit, et al.
Publicado: (2023)